Table 1

Clinical characteristics of the patients and their comparison by each genotype in women and men

Women (n=143)Men (n=128)
Genotype of CYP11B2Genotype of CYP11B2
Total n=271TT n=64CT n=63CC n=16P valueTT n=52CT n=64CC n=12P value
ACEI/ARB, angiotensin-I converting enzyme inhibitor and/or angiotensin receptor blocker; NS, not statistically significant. Values are mean (SD).
At the time of renal biopsy
    Age (year)37.0 (13.4)38.9 (13.4)36.0 (13.0)35.6 (14.0)NS38.4 (12.4)34.4 (14.3)41.0 (12.7)NS
    Urinary protein excretion (g/day)1.36 (1.35)1.17 (1.20)1.02 (1.17)1.63 (1.39)NS1.62 (1.71)1.56 (1.30)1.53 (0.98)NS
    Serum creatinine (mg/dl)0.99 (0.62)0.84 (0.32)0.77 (0.26)0.91 (0.52)NS1.24 (0.75)1.16 (0.87)1.14 (0.27)NS
    Creatinine clearance (ml/min)89.2 (33.1)83.2 (25.6)96.6 (33.5)82.9 (33.4)NS88.2 (33.4)92.0 (39.7)82.5 (24.6)NS
    Blood pressure (mm Hg)NSNS
        Systolic127.6 (18.3)126.6 (18.7)123.6 (17.4)130.8 (25.9)NS130.1 (16.0)128.4 (18.1)133.4 (19.5)NS
        Diastolic77.1 (13.5)76.4 (12.1)74.8 (12.2)76.9 (15.4)NS77.9 (15.0)77.9 (14.4)84.5 (13.2)NS
    Incidence of hypertension (%)36.439.122.035.7NS41.237.566.7NS
During observation
    Observed period (month)92.0 (66.8)102.1 (61.9)86.9 (58.3)61.1 (40.1)0.036691.7 (80.6)92.7 (74.1)105.7 (48.3)NS
    Incidence of progressive renal disease (%)31.029.025.850.0NS29.434.441.7NS
    Corticosteroid (%)28.327.123.233.3NS32.728.333.3NS
    ACEI/ARB (%)40.841.333.950.0NS54.933.341.7NS
Blood pressure (mm Hg)
        Systolic128.3 (16.7)128.1 (17.3)125.6 (17.8)133.1 (22.7)NS127.6 (12.6)129.5 (16.4)132.8 (17.0)NS
        Diastolic77.4 (11.9)76.8 (10.5)75.9 (12.2)78.9 (13.1)NS76.4 (11.6)78.3 (12.7)84.6 (11.7)NS